Nova Leap Health Corp
XTSX:NLH
Nova Leap Health Corp
XTSX:NLH
Price:
0.27 CAD
3.85%
Market Closed
Updated:
May 12, 2024
P/E
Price to Earnings
Price to Earnings
-16.1
Current
-10.4
Median
23.9
Industry
Lower
than median
Lower
than industry value
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
=-16.1
Market Cap
/
23.3m
Net Income
-1.1m
All Countries
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| CA |
|
Nova Leap Health Corp
XTSX:NLH
|
23.3m CAD | -16.1 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
92.4B EUR | 27.5 | |
| US |
|
Cigna Corp
NYSE:CI
|
99B USD | 27.4 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
69.9B USD | 9.5 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
17.5B USD | 40.4 | |
| DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
16.1B EUR | -27.2 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
15.4B USD | 18.2 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.9B EUR | 23.8 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
11.4B EUR | 22.8 | |
| US |
|
DaVita Inc
NYSE:DVA
|
12.1B USD | 14.8 | |
| US |
|
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | -18.6 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
14.2
2-Years Forward
P/E
N/A
3-Years Forward
P/E
N/A
You don't have any saved screeners yet
